Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fetal transfusion.

J T Queenan1

  • 1Department of Obstetrics and Gynecology, Georgetown University, Washington, D.C.

Fetal Therapy
|January 1, 1986
PubMed
Summary
This summary is machine-generated.

Rh-sensitized pregnancies still cause fetal deaths despite prophylaxis. Current treatments include intrauterine transfusions and medications, with newer fetoscopic transfusions showing promise for severe Rh disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Privacy lost.

Obstetrics and gynecology·2001
Same author

Professional liability--some solutions.

Obstetrics and gynecology·2001
Same author

Management of isoimmunization in the presence of multiple maternal antibodies.

American journal of obstetrics and gynecology·2001
Same author

Professional liability--storm warning.

Obstetrics and gynecology·2001
Same author

Embryo freezing to prevent ovarian hyperstimulation syndrome.

Molecular and cellular endocrinology·2001
Same author

Knowledge of likely time of ovulation and contraceptive use in unintended pregnancies.

Advances in contraception : the official journal of the Society for the Advancement of Contraception·2000
Same journal

Ethical issues in prenatal diagnosis and fetal therapy: a Catholic perspective.

Fetal therapy·1989
Same journal

The rights of the embryo and the fetus.

Fetal therapy·1989
Same journal

Prevention and treatment of fetal lung immaturity.

Fetal therapy·1989
Same journal

Genetic correction of hereditary disease.

Fetal therapy·1989
Same journal

Selective birth in a dyzygotic twin pregnancy with discordancy for Down's syndrome.

Fetal therapy·1989
Same journal

First trimester maternal serum lysosomal enzymes: implications for carrier testing and prenatal diagnosis.

Fetal therapy·1989
See all related articles

Area of Science:

  • Perinatology
  • Maternal-Fetal Medicine
  • Neonatology

Background:

  • Rh-sensitized pregnancy remains a cause of fetal mortality despite prophylaxis.
  • Severe Rh disease necessitates intensive fetal and neonatal interventions.

Purpose of the Study:

  • To review current management strategies for Rh-sensitized pregnancies.
  • To highlight advancements in fetal treatment for Rh disease.

Main Methods:

  • Review of established and emerging treatments for fetal Rh disease.
  • Ultrasound detection of fetal heart failure, ascites, and pericardial effusion.
  • Administration of maternal medications (digoxin, diuretics) and fetal transfusions (intrauterine, fetoscopic).

Main Results:

Related Experiment Videos

  • Intrauterine transfusions, preterm delivery, and neonatal care are standard for severe Rh disease.
  • Maternal medication can reverse fetal congestive heart failure.
  • Fetoscopic intravascular transfusions show effectiveness, sometimes reversing hydrops fetalis.

Conclusions:

  • While Rh immune prophylaxis reduces sensitization, fetal deaths still occur.
  • Fetoscopic transfusion represents a significant advancement in managing severe fetal Rh disease.
  • Promising treatments exist, but some methods like plasmapheresis have limited success.